Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA)

CUSIP: 92337R101

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Class A common stock, $0.001 par value per share
Shares outstanding
71,297,491
Total 13F shares
39,258,779
Share change
+824,363
Total reported value
$538,195,352
Put/Call ratio
0%
Price per share
$13.71
Number of holders
84
Value change
+$9,620,413
Number of buys
54
Number of sells
23

Quarterly Holders Quick Answers

What is CUSIP 92337R101?
CUSIP 92337R101 identifies VERA - Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA) as of Q3 2023

As of 30 Sep 2023, Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA) was held by 84 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 39,258,779 shares. The largest 10 holders included COMMODORE CAPITAL LP, FMR LLC, Sofinnova Investments, Inc., Kynam Capital Management, LP, Woodline Partners LP, BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, and Eversept Partners, LP. This page lists 84 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.